(Q33724083)

28 July 2017

title

Venous thromboembolism in cirrhosis (English)

1 reference

28 July 2017

main subject

venous thromboembolism

1 reference

Zhineng J Yang

1

1 reference

28 July 2017

Karen A Costa

series ordinal

2

1 reference

28 July 2017

Enrico M Novelli

series ordinal

3

1 reference

28 July 2017

Roy E Smith

series ordinal

4

1 reference

28 July 2017

publication date

17 October 2012

1 reference

Clinical and Applied Thrombosis-Hemostasis

28 July 2017

published in

1 reference

28 July 2017

volume

20

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

169-178

1 reference

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

The coagulopathy of chronic liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Haemostasis and thrombosis in liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Thrombin generation in patients with cirrhosis: the role of platelets

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

A role for thrombin in liver fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Performance standards for therapeutic abdominal paracentesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Review article: the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Natural history of venous thromboembolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Plasminogen activator inhibitor 1: physiological and pathophysiological roles.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Gastroesophageal variceal hemorrhage

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Natural anticoagulants and the liver

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Structure and function of thrombomodulin: a natural anticoagulant

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

A 21-year experience with major hemorrhage after percutaneous liver biopsy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study

21 June 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Interpretation of the international normalised ratio in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

More on: high thrombin generation and the risk of recurrent venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Low-molecular-weight heparin in patients with advanced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Are chronic hepatitis C viral infections more benign in patients with hemophilia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029612461846

Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048862

Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension

30 October 2018

1 reference

12 December 2020

Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease

1 reference

12 December 2020

Burden of liver disease in the United States: summary of a workshop

1 reference

12 December 2020

Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation

1 reference

12 December 2020

Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis

1 reference

12 December 2020

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity

1 reference

12 December 2020

Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered

1 reference

12 December 2020

High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia

1 reference

12 December 2020

Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?

1 reference

12 December 2020

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding

1 reference

12 December 2020

[Venous thromboembolism and liver cirrhosis]

1 reference

12 December 2020

Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

1 reference

12 December 2020

Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution

1 reference

12 December 2020

Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests

1 reference

12 December 2020

Deep vein thrombosis and pulmonary embolism in cirrhosis patients

1 reference

12 December 2020

Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage

1 reference

12 December 2020

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels

1 reference

12 December 2020

Plasma viscosity changes in patients with liver cirrhosis

1 reference

12 December 2020

Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis

1 reference

12 December 2020

Identifiers

DOI

10.1177/1076029612461846

1 reference

28 July 2017

1 reference

28 July 2017

1 reference